Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin Administration Effect Over Systemic Inflammation Serum Markers in HIV Positive Prediabetic Patients

NCT03774108 is registered in ClinicalTrials.gov with Hospital Civil de Guadalajara as lead sponsor.

NCT NCT03774108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03774108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin Administration Effect Over Systemic Inflammation Serum Markers in HIV Positive Prediabetic Patients
Lead sponsor
Hospital Civil de Guadalajara
Phase
Phase 4
Overall status
Unknown status
Start date
December 15, 2018
Completion date
January 8, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection, prediabetes